Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.8K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

1.1K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Kv7.2 loss-of-function causes early hyperexcitability and network remodelling.

Brain : a journal of neurology·2026
Same author

Unmasking NF1 mosaicism: optical genome mapping identifies a novel t(15;17) translocation in melanocytes.

Journal of medical genetics·2026
Same author

Widespread DNA off-targeting confounds RNA chromatin occupancy studies.

Nature biotechnology·2026
Same author

Expertise is the new infrastructure.

Journal of microscopy·2026
Same author

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trial.

The Lancet. Child & adolescent health·2026

Related Experiment Video

Updated: Oct 2, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.3K

Cellular senescence in neuroblastoma.

Sofia Zanotti1,2,3, Bieke Decaesteker2,3, Suzanne Vanhauwaert2,3

  • 1Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Universiteitsplein 1, Antwerp, 2610, Belgium.

British Journal of Cancer
|February 24, 2022
PubMed
Summary

Cellular senescence in neuroblastoma, a pediatric cancer, presents a complex challenge. Understanding its dynamic nature is key to improving high-risk neuroblastoma treatments and reducing long-term side effects.

More Related Videos

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
08:07

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Published on: February 17, 2016

74.1K
Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.3K

Related Experiment Videos

Last Updated: Oct 2, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.3K
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
08:07

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Published on: February 17, 2016

74.1K
Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

17.3K

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Cellular Senescence

Background:

  • Neuroblastoma is a common pediatric cancer, predominantly affecting children under five.
  • High-risk neuroblastoma has a low treatment success rate and significant long-term side effects.
  • Therapy-induced senescence is a known cancer cell response, but its role in neuroblastoma is complex.

Purpose of the Study:

  • To review the molecular mechanisms of cellular senescence in neuroblastoma.
  • To explore the dual role of senescence in treatment resistance and therapeutic potential.
  • To highlight the need for better models to study senescence in neuroblastoma.

Main Methods:

  • Literature review of molecular mechanisms of senescence in neuroblastoma.
  • Analysis of current treatment strategies and their impact on senescence.
  • Discussion of potential therapeutic avenues targeting senescence.

Main Results:

  • Senescence in neuroblastoma can lead to therapy escape and promote relapse through its secretome.
  • Senescence also offers unique molecular targets for novel combination therapies.
  • Limited understanding of senescence dynamics and signatures hinders therapeutic development.

Conclusions:

  • Cellular senescence in neuroblastoma is a dynamic process with implications for treatment efficacy.
  • Targeting senescence pathways may offer new therapeutic strategies for high-risk neuroblastoma.
  • Further research and appropriate models are crucial to harness senescence for improved patient outcomes.